Cholangiocarcinomas Withdrawn Phase 2 Trials for Gemcitabine (DB00441)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00713687Gemcitabine/Oxaliplatin and Photodynamic Therapy in CholangiocarcinomaTreatment